samedan logo
home > pmps > winter 2001 > quality assurance from the ground up - sourcing raw materials for the herbal marketplace
Pharmaceutical Manufacturing and Packing Sourcer

Quality Assurance From the Ground Up - Sourcing Raw Materials for the Herbal Marketplace

For centuries, medicinal and aromatic plantshave been used all over the world to help improve both helth and beauty. The earlier reports from China relating to the existence of advanced methods of sourcing raw materials from cultivation are more than 2,000 years old. Today there are three basic ways in which the raw materials for the phytopharmaceutical, dietary supplementand cosmetic industries are gathered:

Wild crafting - the reaping of certain plant species in
their natural habitat, usually consisting of a mixture of
different biotypes from different regions, and generally
harvested under different conditions by individual
collectors or collecting organisations

Controlled wild crafting/extensive cultivation - which is
more nature-protective, affording a better homogeneous
quality and preventing species extinction from
over-harvesting while avoiding many of the problems associated
with large-scale cultivation

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:

There are no comments in regards to this article.

By Martin Schneider, Medicinal Plant Cultivation and Purchasing Manager at Linnea, Inc. in Switzerland
Educated in crop sciences and plant breeding at the University of Giessen in Germany, Martin Schneider's career spans nearly 15 years of specialised experience. He has served as a Scientific Assistant and Lecturer in Medicinal Plant Cultivation and Breeding at the University of Geissen; as Manager of the research station for medicinal and aromatic plants in Witterswil, Switzerland, with the responsibility for field trials and the establishment of worldwide cultivation projects; and as Medicinal Plant Cultivation and Purchasing Manager at ELISA Partnership in Ringaskiddy, Ireland. Martin is an active guest speaker at national and international conferences on the specific field of medicinal, aromatic and cosmetic plants.

Martin Schneider
Print this page
Send to a friend
Privacy statement
News and Press Releases

Significant improvement in overall survival with ERLEADA®▼ (apalutamide) for patients with non-metastatic castration-resistant prostate cancer

BEERSE, BELGIUM, May 14, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from the final analysis of the pivotal Phase 3 SPARTAN study demonstrating ERLEADA®▼ (apalutamide) in combination with androgen deprivation therapy (ADT) significantly improved overall survival (OS), compared to ADT alone, in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) who were at high risk of developing metastases.1 Results will be presented at the American Society of Clinical Oncology (ASCO) Virtual Scientific Programme (Abstract #5516) beginning on Friday 29th May.
More info >>

White Papers

Systems Engineering for Complex Portable Medical Device Development


As the demand for complex, portable medical devices continues to grow, reducing risk and increasing efficiency during the development of these products should be paramount. Taking a systems-engineering (SE) approach to development provides a holistic, organized, and deliberate method for identifying as well as reducing both patient and business risks early in the process. Furthermore, it facilitates efficient progression throughout the entire product development life cycle.
More info >>




©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement